Monday, 21 May 2018

Microbiome Drugs for Immunity and Gut Related Diseases

Microbiome drugs can be used in the treatment of inflammatory bowel disease (IBD), autoimmune diseases, cancers, diabetes, obesity, gastrointestinal diseases, skin diseases, mental disorders, and other diseases and disorders. Microbiome refers to the collective genomes of microbes that live inside the human body. Lots of microbes are present in the digestive tract, respiratory mucosa, oral cavity, skin, and other parts of the human body. They have influence on body functions including digestion and immune conditions. They usually do not cause any side effects since they are already residing in the body.

To get more details :

Probiotics to Witness Impressive Growth Through 2022

Major types of microbiome products include probiotics, prebiotics, small molecules, biological drugs, and others. Probiotics are predicted to have the largest market share owing to the rise in research activities in probiotic strains and extensive applications in food & beverages and dietary supplements. They are considered as healthy bacteria and are used for treating several types of immune system and gut related diseases. These special bacteria are utilized for treating ailments related to digestion, intestines, gastrointestinal tract, and bowel function. They act as a barrier in case of food poisoning.

As a result, many drug manufacturers are using microbiomes to create more effective drugs. To put this in perspective, recently Herbalife, a nutrition company introduced a powdered probiotic called Simply Probiotic. It consists of around one billion active probiotic cultures per serving. This easy to use probiotic is portable and can be well-preserved at room temperature. It can be easily formulated with cold, hot, or frozen foods and is considered suitable for gut balance.

Prebiotics are non-digestible carbohydrate, which helps improve growth of microbes already present in the body. The blend of prebiotics and probiotics is called as Synbiotics, which are also utilized to develop effective drugs. For instance, JUS By Julie, a blended juice and food company introduced a Probiotic + Prebiotics Single Serving Food and Drink Mix. This product contains two billion CFU’s of GanedenBC30 vegan probiotics and raw prebiotics. IT is made up of a special tasteless vegan probiotic and can be consumed with hot and cold meals and beverages.

Market Overview

Based on a report added to the repository of Radiant Insights, Inc.; the global microbiome market is anticipated to grow rapidly by 2022. Increase in digestive related diseases, rising R&D activities, strong governments backing, and availability of pipeline drugs can drive the market over the forecast period (2017 to 2022). However, lack of awareness about the usage of microbiome drugs can hamper market growth during the forecast period.

United States is considered as one of the attractive markets. Southeast Asia, on the other hand, is predicted to witness the fastest growth in near future. This expansion is accredited to increasing governments support.

Some of the leading players in the market are include MicroBiome Therapeutics, Pfizer, Ritter Pharmaceuticals, Enterome Bioscience, and MaaT Pharma.

To get free request sample :

No comments:

Post a Comment